Orphan Status News
Most Popular Orphan Status Story
Aspreva, Roche put CellCept on ice
Shares of Aspreva Pharmaceuticals slipped a bit this morning after the company and Roche announced that they would not be pushing ahead with a regulatory filing for CellCept, a new therapy for lupus Read more...
Latest Headlines
- March 10, 2010
- January 8, 2010
- May 9, 2008
- March 20, 2008
- October 29, 2007
- October 19, 2007
- September 10, 2007
- August 20, 2007
- August 15, 2007
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
